HCPCS Code Descriptor:
Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
50242-0135-01, 50242-0136-01, 50242-0143-01, 50242-0138-01, 50242-0137-01
Route of Administration:
ACTEMRA is a COVID-19 drug manufactured by Genentech and administered via the Intravenous route of administration. The Q Code: Q0249 is aligned to the drug ACTEMRA.